Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cholesterol management statements for supplements are structure/function claims -- CRN.

This article was originally published in The Tan Sheet

Executive Summary

CHOLESTEROL MANAGEMENT SUPPLEMENTS STATEMENTS ARE STRUCTURE/FUNCTION CLAIMS, the Council for Responsible Nutrition maintains in a Dec. 1 letter to FDA. A claim that a dietary supplement will prevent or treat heart disease is "clearly a drug claim," CRN acknowledges, and a claim that such a product will reduce the risk of heart disease "may be a health claim subject to" the requirements of the Nutrition Labeling & Education Act. However, the group argues, "a claim that a dietary supplement...will assist in maintaining normal or healthy levels of cholesterol is just as clearly a structure/function claim as is `calcium builds strong bones.'"

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel